Not Yet RecruitingNot Applicable

Evaluation of the Magneto eTrieve™ PE Kit for Endovascular Thrombectomy in Subjects With Acute Pulmonary Embolism

130 participantsStarted 2026-07

Plain-language summary

Prospective, multi-center, open-label, single-arm clinical study of the safety and effectiveness of the eTrieve™ in subjects presenting with signs and symptoms of acute intermediate-risk pulmonary embolism

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Hematocrit \< 28%
✕. Platelets \< 100,000/µL
✕. Serum creatinine \> 1.8 mg/dL
✕. INR \> 3

What they're measuring

MAE

Timeframe: 48 hours

RV/LV ratio

Timeframe: 48 hours

Trial details

NCT IDNCT05821426

SponsorMagneto Thrombectomy Solutions

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2027-07

Contact for this trial

Tami Abudi

+972 (52) 5989833 tami@magts.com

View on ClinicalTrials.gov More Pulmonary Embolism trials